|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
PRGO | Kochan Sharon | EVP & President Rx | Mar 05 | Option Exercise | 41.04 | 4,057 | 166,499 | 38,748 | Mar 09 09:19 PM |
PRGO | Kochan Sharon | EVP, GM International | Jun 29 | Option Exercise | 54.56 | 2,285 | 124,670 | 31,307 | Jul 01 01:59 PM |
PRGO | Kochan Sharon | EVP, GM International | Mar 06 | Option Exercise | 53.17 | 2,062 | 109,637 | 21,555 | Mar 10 08:55 PM |
PRGO | Kochan Sharon | EVP, GM International | Oct 08 | Option Exercise | 51.94 | 7,304 | 379,370 | 19,493 | Oct 10 03:46 PM |
PRGO | Kochan Sharon | EVP, GM International | Feb 26 | Option Exercise | 48.29 | 1,315 | 63,501 | 12,937 | Feb 28 03:16 PM |
PRGO | Kochan Sharon | EVP, GM International | Sep 07 | Sale | 81.36 | 318 | 25,874 | 10,031 | Sep 11 04:56 PM |
PRGO | Kochan Sharon | EVP, GM International | Aug 31 | Sale | 79.03 | 1,500 | 118,545 | 10,349 | Sep 05 02:33 PM |
PRGO | Kochan Sharon | EVP, GM International | Aug 21 | Option Exercise | 77.58 | 1,113 | 86,347 | 10,707 | Aug 23 08:08 PM |
PRGO | Kochan Sharon | EVP, GM International | Aug 22 | Option Exercise | 91.52 | 1,336 | 122,271 | 10,088 | Aug 24 03:51 PM |
PRGO | Kochan Sharon | EVP, GM International | Aug 19 | Option Exercise | 91.83 | 1,015 | 93,207 | 6,898 | Aug 23 04:57 PM |
PRGO | Kochan Sharon | EVP, GM International | Mar 02 | Sale | 125.28 | 1,490 | 186,667 | 5,883 | Mar 04 02:43 PM |
PRGO | Kochan Sharon | EVP, GM International | Aug 21 | Option Exercise | 186.89 | 967 | 180,723 | 7,731 | Aug 25 06:20 PM |
PRGO | Kochan Sharon | EVP, GM International | Nov 10 | Option Exercise | 90.65 | 5,367 | 486,519 | 10,767 | Nov 12 04:37 PM |
PRGO | Kochan Sharon | EVP, GM International | Nov 10 | Sale | 156.36 | 5,367 | 839,184 | 5,400 | Nov 12 04:37 PM |
PRGO | Kochan Sharon | EVP, GM International | Sep 03 | Sale | 150.00 | 1,116 | 167,400 | 5,400 | Sep 04 04:42 PM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | Nov 15 | Sale | 152.53 | 455 | 69,401 | 5,086 | Nov 19 02:54 PM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | Aug 29 | Option Exercise | 58.82 | 1,323 | 77,819 | 6,864 | Sep 03 01:21 PM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | Aug 29 | Sale | 120.98 | 3,467 | 419,443 | 5,541 | Sep 03 01:21 PM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | Aug 19 | Option Exercise | 118.74 | 1,530 | 181,672 | 7,022 | Aug 21 04:58 PM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | May 14 | Option Exercise | 58.82 | 2,647 | 155,697 | 8,139 | Aug 21 04:57 PM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | May 14 | Sale | 119.64 | 2,647 | 316,687 | 5,492 | Aug 21 04:57 PM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | May 14 | Option Exercise | 58.82 | 2,647 | 155,697 | 8,139 | May 16 03:02 PM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | May 14 | Sale | 119.64 | 2,647 | 316,687 | 5,492 | May 16 03:02 PM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | Nov 14 | Option Exercise | 20.50 | 2,912 | 59,696 | 7,772 | Nov 16 03:08 PM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | Aug 27 | Option Exercise | 90.29 | 10,657 | 962,248 | 11,593 | Aug 29 03:14 PM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | Aug 27 | Sale | 110.27 | 3,381 | 372,820 | 8,212 | Aug 29 03:14 PM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | Aug 28 | Sale | 110.80 | 3,352 | 371,402 | 4,860 | Aug 29 03:14 PM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | Feb 10 | Option Exercise | 32.90 | 5,281 | 173,726 | 7,407 | Feb 14 03:10 PM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | Feb 10 | Sale | 93.18 | 4,100 | 382,038 | 4,713 | Feb 14 03:10 PM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | Feb 13 | Sale | 94.75 | 1,000 | 94,750 | 4,307 | Feb 14 03:10 PM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | Aug 30 | Option Exercise | 20.50 | 2,913 | 59,716 | 7,039 | Sep 01 04:06 PM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | Aug 30 | Sale | 96.22 | 5,216 | 501,903 | 4,126 | Sep 01 04:06 PM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | Aug 25 | Option Exercise | 90.94 | 6,395 | 581,561 | 7,571 | Aug 29 07:20 PM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | Aug 23 | Option Exercise | 15.47 | 2,500 | 38,675 | 5,491 | Aug 25 06:00 PM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | Aug 23 | Sale | 89.27 | 3,934 | 351,192 | 2,991 | Aug 25 06:00 PM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | Mar 02 | Option Exercise | 14.95 | 7,500 | 112,125 | 11,925 | Mar 04 02:47 PM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | Mar 02 | Sale | 76.38 | 7,500 | 572,822 | 4,425 | Mar 04 02:47 PM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | Feb 14 | Option Exercise | 35.85 | 2,588 | 92,780 | 7,013 | Feb 15 01:38 PM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | Feb 14 | Sale | 73.90 | 2,588 | 191,253 | 4,425 | Feb 15 01:38 PM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | Feb 08 | Sale | 71.90 | 3,117 | 224,112 | 4,425 | Feb 09 01:23 PM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | Feb 04 | Option Exercise | 25.09 | 5,607 | 140,698 | 10,455 | Feb 08 01:13 PM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | Feb 04 | Sale | 72.00 | 5,607 | 403,704 | 7,542 | Feb 08 01:13 PM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | Aug 30 | Option Exercise | 0.00 | 4,098 | 0 | 12,937 | Sep 01 06:23 PM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | Sep 01 | Sale | 58.24 | 3,600 | 209,664 | 7,542 | Sep 01 06:23 PM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | May 11 | Option Exercise | 35.85 | 2,588 | 92,780 | 6,393 | May 13 05:23 PM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | May 11 | Sale | 62.74 | 2,588 | 162,371 | 3,805 | May 13 05:23 PM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | May 05 | Sale | 61.37 | 11,788 | 723,381 | 3,805 | May 07 03:34 PM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | Nov 13 | Option Exercise | 20.50 | 2,913 | 59,716 | 18,506 | Nov 17 06:31 PM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | Nov 13 | Sale | 40.18 | 2,913 | 117,044 | 15,593 | Nov 17 06:31 PM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | Nov 05 | Option Exercise | 14.95 | 7,500 | 112,125 | 20,593 | Nov 09 03:13 PM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | Nov 05 | Sale | 38.18 | 7,500 | 286,350 | 16 | Nov 09 03:13 PM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | Nov 10 | Option Exercise | 16.83 | 7,913 | 133,166 | 23,607 | Nov 12 08:18 AM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | Nov 10 | Sale | 33.40 | 7,913 | 264,332 | 15,694 | Nov 12 08:18 AM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | Aug 20 | Option Exercise | 14.88 | 10,000 | 148,850 | 25,694 | Aug 22 05:52 PM |
PRGO | Kochan Sharon | Executive VP U.S. Generics | Aug 20 | Sale | 35.44 | 11,567 | 409,883 | 15,694 | Aug 22 05:52 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite